Pharmaceuticals

Global Calcium Channel Blocker Market Trends and Growth Analysis 2025–2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Calcium Channel Blocker Market Expected To Expand Between 2025 And 2029?

The calcium channel blocker market has experienced robust expansion in recent years. It is projected to grow from $15.56 billion in 2024 to $16.46 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.8%. This historical growth can be attributed to several factors, including an increased incidence of cardiovascular diseases, an aging population, advancements in medical research, evolving lifestyles, and heightened awareness.

The calcium channel blocker market is set for significant expansion over the next few years, projected to achieve a size of $21.59 billion by 2029. This growth is expected to occur at a compound annual growth rate (CAGR) of 7.0%. Several factors contribute to this anticipated rise during the forecast period, including the increasing global incidence of cardiovascular diseases, the adoption of personalized medicine, improved access to healthcare, the broadening of treatment indications, favorable regulatory approvals, and geographical market expansion. Furthermore, significant trends identified for this period encompass general market growth, technological progress, the evolving regulatory framework, competitive landscape analysis, and shifts in patient preferences and awareness.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9428&type=smp

Which Major Market Drivers Are Shaping The Future Of The Calcium Channel Blocker Market?

The rising incidence of cardiovascular diseases is anticipated to stimulate the future expansion of the calcium channel blocker market. These conditions, which impact the heart or blood vessels, are a significant health concern. Calcium channel blockers (CCBs) are utilized to decrease the probabilities of heart failure and stroke. Consequently, the growing frequency of cardiovascular diseases will lead to an increased requirement for calcium channel blockers. For instance, in August 2022, a report from the American College of Cardiology, a US-based non-profit medical association, projected that all four major cardiovascular risk factors in the United States would rise between 2025 and 2060. Diabetes is expected to see the most substantial percentage increase, at 39.3% to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Researchers also noted that the largest projected increases in specific cardiovascular disease rates were for stroke (33.8% to 15 million) and heart failure (33.4% to 13 million), followed by ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million). Thus, the increasing prevalence rate of cardiovascular diseases is a primary driver for the growth of the calcium channel blocker market.

What Are The Leading Segments Analyzed In The Calcium Channel Blocker Market?

The calcium channel blocker market covered in this report is segmented –

1) By Drug Class: Dihydropyridine, Benzothiazepine, Phenylalkylamine, Other Drug Classes

2) By Disease Indications: Hypertension, Chest Pain, Arrhythmias

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Dihydropyridine: Amlodipine, Nifedipine, Felodipine, Nicardipine, Isradipine

2) By Benzodiazepine: Diazepam

3) By Phenylalkylamine: Verapamil

4) By Other Drug Classes: Bepridil, Lercanidipine, Cilnidipine

How Are Trends Influencing The Calcium Channel Blocker Market?

Product innovation is a key trend gaining traction in the calcium channel blocker market. Major companies in the calcium channel blockers market are prioritizing the development of innovative products to sustain their market position. For instance, in June 2022, CMP Pharma, a US-based pharmaceutical manufacturing company, launched Norliqva, which is the first and only oral liquid solution of the besylate salt of amlodipine, a long-acting calcium channel blocker. The unique aspect of Norliqva is that it serves as an amlodipine liquid solution for treating hypertension in people 6 years of age and older. Norliqva prevents the difficulties and irregularities often associated with crushing or compounding amlodipine tablets, thus ensuring uniform dosing and bioequivalence. Norliqva is intended for a specific group of patients who require amlodipine but struggle with or are unable to swallow.

Which Major Industry Participants Are Leading The Calcium Channel Blocker Market Growth?

Major companies operating in the calcium channel blocker market include Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Bausch Health Companies Inc., Lupin Pharmaceuticals Inc., Cadila Healthcare Limited, Covis Pharma BV, Glenmark Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Sofgen Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Knoll Healthcare Private Limited, Sanofi S.A., Clearsynth Labs Ltd., Searle LLC, Bayer AG, AstraZeneca plc, Wyeth-Ayerst Lederle Inc., GlaxoSmithKline Plc., AbbVie Inc., Silvergate Pharmaceuticals Inc., Exela Pharma Sciences LLC, Arbor Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/calcium-channel-blocker-global-market-report

Which Geographies Are Emerging As Strong Markets For The Calcium Channel Blocker Industry?

North America was the largest region in the calcium channel blocker market in 2024. The regions covered in the calcium channel blocker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Calcium Channel Blocker Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9428&type=smp

Browse Through More Reports Similar to the Global Calcium Channel Blocker Market 2025, By The Business Research Company

Anti Hypertensive Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report

Drugs For Benign Prostatic Hypertrophy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-benign-prostatic-hypertrophy-global-market-report

Antiglaucoma Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antiglaucoma-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795